Boston Therapeutics, Inc.

BTHEOTCHealthcare

$0.01

+$0.00(+0.00%)

Market Cap$0

P/E Ratio—

52W High$0.0119

52W Low$0.0091

Avg Volume170K

Open$0.01

Beta-0.78

Earnings Financials Revenue

Boston Therapeutics, Inc. (BTHE) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

BTHE · earnings · updated Jun 9, 2026

Latest Earnings

Q4 FY2021Report Date: Oct 4, 2021

EPS Actual

-$2.70

Revenue

—

Fiscal Period

Q4 FY2021

FY ends December

Report Date

Oct 4, 2021

After Market Close

BTHE reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q4 FY2021	Oct 4, 2021	—	-$2.70	—	—	—	—
— Q2 FY2021	Jun 30, 2021	—	-$0.00	—	—	—	—
— Q1 FY2021	Mar 31, 2021	—	-$0.02	—	—	—	—
— Q4 FY2020	Dec 31, 2020	—	-$0.00	—	$0.00B	—	—
— Q3 FY2020	Sep 30, 2020	—	-$0.00	—	$0.00B	—	—
— Q2 FY2020	Jun 30, 2020	—	-$0.00	—	$0.00B	—	—
— Q1 FY2020	Mar 31, 2020	—	-$0.00	—	$0.00B	—	—
— Q4 FY2019	Dec 31, 2019	—	-$0.02	—	$0.00B	—	—

Q4 FY2021

Oct 4, 2021

EPS Actual

-$2.70

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2021

Jun 30, 2021

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2021

Mar 31, 2021

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2020

Dec 31, 2020

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q3 FY2020

Sep 30, 2020

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2020

Jun 30, 2020

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2020

Mar 31, 2020

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2019

Dec 31, 2019

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

No analyst estimates available for BTHE.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q4 FY2021	Oct 4, 2021	—	No price data	—	—
— Q2 FY2021	Jun 30, 2021	—	No price data	—	—
— Q1 FY2021	Mar 31, 2021	—	No price data	—	—
— Q4 FY2020	Dec 31, 2020	—	No price data	—	—
— Q3 FY2020	Sep 30, 2020	—	No price data	—	—
— Q2 FY2020	Jun 30, 2020	—	No price data	—	—
— Q1 FY2020	Mar 31, 2020	—	No price data	—	—
— Q4 FY2019	Dec 31, 2019	—	No price data	—	—

Q4 FY2021—

Report Date

Oct 4, 2021

EPS Beat/Miss

—

Price Before

—

Price After

—

Q2 FY2021—

Report Date

Jun 30, 2021

EPS Beat/Miss

—

Price Before

—

Price After

—

Q1 FY2021—

Report Date

Mar 31, 2021

EPS Beat/Miss

—

Price Before

—

Price After

—

Q4 FY2020—

Report Date

Dec 31, 2020

EPS Beat/Miss

—

Price Before

—

Price After

—

Q3 FY2020—

Report Date

Sep 30, 2020

EPS Beat/Miss

—

Price Before

—

Price After

—

Q2 FY2020—

Report Date

Jun 30, 2020

EPS Beat/Miss

—

Price Before

—

Price After

—

Q1 FY2020—

Report Date

Mar 31, 2020

EPS Beat/Miss

—

Price Before

—

Price After

—

Q4 FY2019—

Report Date

Dec 31, 2019

EPS Beat/Miss

—

Price Before

—

Price After

—

Beat Rate0 / 8 quarters

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Boston Therapeutics, Inc. (BTHE) most recently reported earnings on October 4, 2021 for Q4 FY2021, posting EPS of $-2.70 (in line with the analyst consensus of —). The next BTHE earnings date is expected around September 1, 2026.

Each quarter, investors track BTHE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BTHE revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

BTHE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

BTHE earnings · 3 questions

Boston Therapeutics, Inc.'s next earnings report is expected around September 1, 2026. BTHE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BTHE historically reports after market close (AMC).

BTHE earnings datewhen is BTHE earningsBTHE next earnings datewhen does BTHE report earningsBTHE earnings calendar

▸ Source: FMP · Boston Therapeutics, Inc. SEC filings · US GAAP · Boston Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026